PCO Clinical Trial
Official title:
The Added Value of n Acetyle Cysteine and Chromium to Clomiphene Citrate in PCO
Verified date | April 2021 |
Source | Aljazeera Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
PCO is one of the factors associated with delayed conception
Status | Completed |
Enrollment | 108 |
Est. completion date | May 15, 2020 |
Est. primary completion date | May 2, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 40 Years |
Eligibility | Inclusion Criteria: - women with PCO Exclusion Criteria: - women who donot have PCO |
Country | Name | City | State |
---|---|---|---|
Egypt | Algazeerah | Giza | |
Egypt | Algazeerah and Kasralainy hospital | Giza |
Lead Sponsor | Collaborator |
---|---|
Aljazeera Hospital | Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The number of women who will have mature follicles wih their size and number of mqture follicles The number of women who will have mature follicles | Assessment of women in both groups for size and number of follicles | within 2 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06302166 -
Effects of HICT and Intermittent Fasting on PCOS
|
N/A | |
Completed |
NCT05952349 -
Effect of Metformin and Combination of Olive Oil Plus Nutritional Supplements on Inflammatory Markers IL-6 and IL-8 in PCOS.
|
Phase 2 | |
Recruiting |
NCT05601336 -
of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO
|
Phase 3 | |
Recruiting |
NCT04887402 -
Parameters Declaring PCO Infertile Patients Either Sensitive or Resistant to Different Doses of Clomiphene Citrate.
|
||
Completed |
NCT01279512 -
Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Completed |
NCT05804149 -
Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women
|
Phase 2 | |
Not yet recruiting |
NCT05951400 -
Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist in With Expected High Ovarian Response Undergoing in Vitro Fertilization
|
Phase 2/Phase 3 |